CETP Gets Another Go: NewAmsterdam Phase III Trial Shows Safety And Efficacy

 
• By Jessica Merrill
  
Obicetrapib showed a benefit on LDL-C reduction in patients with HeFH • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cardiovascular

More from Therapeutic Category